Article
Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy.
Medical oncology (Northwood, London, England) - 1 Oct 2014
Sekine Akimasa, Satoh Hiroaki, Iwasawa Tae, Tamura Katsumi, Hayashihara Kenji, Saito Takefumi, Kato Terufumi, Arai Mito, Okudela Koji, Ohashi Kenichi, Ogura Takashi
Abstract excerpt
The aim of this study was to explore prognostic factors for non-small cell lung cancer (NSCLC) patients with brain metastases (BM) on the basis of EGFR mutation status. Among 779 consecutive NSCLC patients who underwent EGFR mutation screening, all 197 patients with BM were divided according to the EGFR mutation status. The prognostic factors, including patient characteristics at the time of BM diagnosis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.